Citi Pharma Ltd Reports Strong Half-Year Performance with Strategic Expansion Plans
LAHORE: Citi Pharma Ltd (CPHL) announced its financial results for the first half of the fiscal year 2026, reporting a notable increase in earnings per share (EPS) by 33% year-over-year,